01/26/2017 - 10:05am

Actelion will spin off its drug discovery operations and early-stage clinical development assets into a newly created company to its shareholders in the form of a dividend immediately prior to the deal closing.

01/26/2017 - 9:33am

FDA determines Dalfampridine Extended-Release tablets, 10 mg is bioequivalent to Amprya.

01/26/2017 - 8:19am

McKesson reported revenues of $50.1 billion, up 5%, for the third quarter ended Dec. 31.

01/25/2017 - 2:23pm

Captain Mark Kelly will discuss how to better manage teams, deal with changing circumstances and use detailed plans to accomplish remarkable things in the face of seemingly insurmountable obstacles.

01/25/2017 - 1:39pm
The FDA’s approval of the new formulation comes a little more than a year after it approved the nasal spray in a 4-mg formulation. 

 

01/25/2017 - 10:50am
The drug had U.S. sales of $204 million for the 12 months ended September 2016, according to QuintilesIMS data. 
01/24/2017 - 1:27pm

The bill reached impressive levels of bipartisan support in the prior Congress, with half of the Senate and two-thirds of the U.S. House of Representatives co-sponsoring the measure.

01/24/2017 - 11:08am
The drug is indicated to treat plaque psoriasis in patients 18 years of age or older and had sales estimated at $24 million for the 12 months ended November 2016, the company said. 
01/24/2017 - 10:29am

The news was announced in conjunction with the company's fourth quarter earnings call, and is part of the company's ongoing portfolio management.